NCT01440829View on ClinicalTrials.gov

The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Decompensated CirrhosisPortal HypertensionBleeding VaricesRefractory Ascites
Interventions
DRUG

L-ornithine-L-aspartate

The patients will be treated with LOLA (30g per day) for a week after TIPS procedure.

Trial Locations (1)

710032

Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an

All Listed Sponsors
lead

Air Force Military Medical University, China

OTHER

NCT01440829 - The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS | Biotech Hunter | Biotech Hunter